Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
292
Appointments
143
Departures
34
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,427 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Global Crossing Airlines Group Inc. | David Sandberg | directordirector | Appointed | Aug 11, 2026 | SEC 8-K |
| Aug 17, 2026 | HORIZON BANCORP INC /IN/ | Nicholas J. Ritter | directordirector | Appointed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | HORIZON BANCORP INC /IN/ | Charles W. Sulerzyski | directordirector | Appointed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | IDEX CORP /DE/ | L. Paris Watts-Stanfield | DirectorDirector | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Ispire Technology Inc. | Steven Przybyla | PresidentPresident | Appointed | Aug 11, 2026 | SEC 8-K |
| Aug 17, 2026 | KAISER ALUMINUM CORP | Fred Stephan | Chief Executive Officer and PresidentCEO | Appointed | Nov 1, 2026 | SEC 8-K |
| Aug 17, 2026 | KAISER ALUMINUM CORP | Keith A. Harvey | Chief Executive Officer and PresidentCEO | Departed | Nov 1, 2026 | SEC 8-K |
| Aug 17, 2026 | KULICKE & SOFFA INDUSTRIES INC | Raj Talluri | President and Chief Executive OfficerCEO | Appointed | Sep 1, 2026 | SEC 8-K |
| Aug 17, 2026 | KULICKE & SOFFA INDUSTRIES INC | Raj Talluri | DirectorDirector | Appointed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | L3HARRIS TECHNOLOGIES, INC. /DE/ | Sam Mehta | President and Chief Executive OfficerCEO | Appointed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | L3HARRIS TECHNOLOGIES, INC. /DE/ | Christopher Kubasik | Chairman and Chief Executive OfficerCEO | Departed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | L3HARRIS TECHNOLOGIES, INC. /DE/ | Christopher Kubasik | member of the Company’s Boardmember of the Company’s Board | Departed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Paula A. Johnson, M.D., M.P.H. | Class III directorClass III director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Sophie Kornowski, Pharm.D. | Class I directorClass I director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Nancy C. Andrews, M.D., Ph.D. | Class III directorClass III director | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Nancy C. Andrews, M.D., Ph.D. | Class II directorClass II director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Hervé Hoppenot | Class II directorClass II director | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Hervé Hoppenot | Class III directorClass III director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Neuronetics, Inc. | Francis X. Brown III | interim principal financial and accounting officerCFO | Departed | Aug 11, 2026 | SEC 8-K |
| Aug 17, 2026 | Neuronetics, Inc. | Nir Naor | principal financial and accounting officerCFO | Appointed | Aug 12, 2026 | SEC 8-K |
- Global Crossing Airlines Group Inc.Appointed
David Sandberg director
Filed Aug 17, 2026Effective Aug 11, 2026SEC 8-K
- HORIZON BANCORP INC /IN/Appointed
Nicholas J. Ritter director
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- HORIZON BANCORP INC /IN/Appointed
Charles W. Sulerzyski director
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- IDEX CORP /DE/Departed
L. Paris Watts-Stanfield Director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Ispire Technology Inc.Appointed
Steven Przybyla President
Filed Aug 17, 2026Effective Aug 11, 2026SEC 8-K
- KAISER ALUMINUM CORPAppointed
Fred Stephan CEO
Filed Aug 17, 2026Effective Nov 1, 2026SEC 8-K
- KAISER ALUMINUM CORPDeparted
Keith A. Harvey CEO
Filed Aug 17, 2026Effective Nov 1, 2026SEC 8-K
- KULICKE & SOFFA INDUSTRIES INCAppointed
Raj Talluri CEO
Filed Aug 17, 2026Effective Sep 1, 2026SEC 8-K
- KULICKE & SOFFA INDUSTRIES INCAppointed
Raj Talluri Director
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- L3HARRIS TECHNOLOGIES, INC. /DE/Appointed
Sam Mehta CEO
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- L3HARRIS TECHNOLOGIES, INC. /DE/Departed
Christopher Kubasik CEO
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- L3HARRIS TECHNOLOGIES, INC. /DE/Departed
Christopher Kubasik member of the Company’s Board
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Paula A. Johnson, M.D., M.P.H. Class III director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Sophie Kornowski, Pharm.D. Class I director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Departed
Nancy C. Andrews, M.D., Ph.D. Class III director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Nancy C. Andrews, M.D., Ph.D. Class II director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Departed
Hervé Hoppenot Class II director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Hervé Hoppenot Class III director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Neuronetics, Inc.Departed
Francis X. Brown III CFO
Filed Aug 17, 2026Effective Aug 11, 2026SEC 8-K
- Neuronetics, Inc.Appointed
Nir Naor CFO
Filed Aug 17, 2026Effective Aug 12, 2026SEC 8-K